Multiple Myeloma

Showing NaN - NaN of 141

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Nov 1, 2021

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Multiple Myeloma Trial in Atlanta, Boston (ACE-011, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +3 more
Oct 28, 2021

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +32 more
Oct 8, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

Completed
  • Acute Leukemia
  • +4 more
  • Atlanta, Georgia
    Northside Hospital
Sep 1, 2021

Multiple Myeloma Trial in United States (hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Terminated
  • Multiple Myeloma
  • hLL1-DOX (the doxorubicin conjugate of milatuzumab)
  • Orlando, Florida
  • +4 more
Aug 12, 2021

Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)

Completed
  • Multiple Myeloma
  • +2 more
  • milatuzumab
  • Atlanta, Georgia
  • +5 more
Aug 12, 2021

Multiple Myeloma Trial in United States (MyHOPE™ for Multiple Myeloma, MyHope HCP Portal)

Terminated
  • Multiple Myeloma
  • MyHOPE™ for Multiple Myeloma
  • MyHope HCP Portal
  • Mobile, Alabama
  • +33 more
Aug 5, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Multiple Myeloma Trial in United States (BION-1301)

Terminated
  • Multiple Myeloma
  • BION-1301
  • West Hollywood, California
  • +6 more
Mar 8, 2021

Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)

Active, not recruiting
  • Multiple Myeloma
  • panobinostat capsules
  • +2 more
  • Fayetteville, Arkansas
  • +79 more
Mar 15, 2021

Multiple Myeloma Trial in United States (bb21217)

Active, not recruiting
  • Multiple Myeloma
  • bb21217
  • San Francisco, California
  • +10 more
Mar 17, 2021

Connect® MM- The Multiple Myeloma Disease Registry

Active, not recruiting
  • Multiple Myeloma
    • Huntsville, Alabama
    • +252 more
    Jan 21, 2021

    Multiple Myeloma Trial in United States (Denosumab Q4W)

    Recruiting
    • Multiple Myeloma
    • Denosumab Q4W
    • Atlanta, Georgia
    • +6 more
    Jan 21, 2021